top
Search terms
Results 1 - 10 of 99 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 10
Ehjournal

Blood pressure increases progressively from 15 mmHg (worms) to 170/70 mmHg (birds) according to the increase in metabolic rate. From the worms, through the arthropods, the mollusks, and the reptiles ...

European Heart Journal, SPECIAL ARTICLE, Dominique A. Bettex, René Prêtre, Pierre-Guy Chassot

Date : 07/09/2014 Item size : 279222 bytes
Ejhf

Introduction Chronic heart failure (CHF) is a common, serious, and costly disease whose clinical course is characterized by recurrent hospitalizations due to fluid overload and/or worsening of renal ...

European Journal of Heart Failure, Dendale, Paul, De Keulenaer, Gilles, Troisfontaines, Pierre, Weytjens, Caroline, Mullens, Wilfried, Elegeert, Ivan, Ector, Bavo, Houbrechts, Marita, Willekens, ...

Date : 01/03/2012 Item size : 175346 bytes
Ejhf

Plasma volume expansion in patients with heart failure (HF) is associated with neurohumeral activation; symptom and signs of pulmonary congestion and peripheral oedema; an increase in ...

European Journal of Heart Failure, Pitt, Bertram, Gheorghiade, Mihai

Date : 01/12/2011 Item size : 103236 bytes
Ehjcardiovascrec

In the present studies, eprosartan's ability to provide end-organ protection was evaluated in a model of cardiomyopathy and renal failure in stroke-prone rats (SP). Echocardiographic (i.e. 2-D ...

Cardiovascular Research, Original Article, Frank C. Barone, Robert W. Coatney, Sudeep Chandra, Susanta K. Sarkar, Allen H. Nelson, Lisa C. Contino, David P. Brooks, Wallace G. Campbell, Eliot H. ...

Date : 01/06/2001 Item size : 322347 bytes
Ehjcardioimaging

Abstract Aims Patients with chronic kidney disease are at high risk of cardiovascular morbidity and mortality. Left ventricular hypertrophyPaediatric echocardiographyKidney diseaseIndexation ...

European Heart Journal - Cardiovascular Imaging, Clinical/Original Paper, John M. Simpson, Alexandra Savis, Debbie Rawlins, Shakeel Qureshi, Manish D. Sinha

Date : 01/04/2010 Item size : 230663 bytes
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Anne E. de Leeuw, Rudolf A. de Boer

Date : 01/10/2016 Item size : 586778 bytes
Ehjcvp

[...]SGLT2 inhibition represents a novel treatment, which might be a promising target not only to (further) reduce blood glucose but also to target other cardiovascular risk factors. SGLT2 ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Anne E. de Leeuw, Rudolf A. de Boer

Date : 18/04/2016 Item size : 590679 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcardiovascrec

Abstract Aims Diabetic cardiomyopathy is characterized by the production of a disorganized fibrotic matrix in the absence of coronary atherosclerosis and hypertension. Introduction Diabetic ...

Cardiovascular Research, Original Article, Ilana Talior-Volodarsky, Kim A. Connelly, Pamma D. Arora, Donald Gullberg, Christopher A. McCulloch

Date : 01/11/2012 Item size : 363435 bytes
Ehjcardiovascrec

Abstract Objective: To assess the long-term efficacy of vasopressin (AVP) V1a and V2 receptor blockade with conivaptan, alone and in combination with angiotensin converting enzyme (ACE) inhibition on ...

Cardiovascular Research, Original Article, Mareo Naitoh, John Risvanis, Leanne C. Balding, Colin I. Johnston, Louise M. Burrell

Date : 01/04/2002 Item size : 257113 bytes